Lucas Wiessing

7.9k total citations · 4 hit papers
82 papers, 5.6k citations indexed

About

Lucas Wiessing is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lucas Wiessing has authored 82 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 35 papers in Hepatology and 33 papers in Infectious Diseases. Recurrent topics in Lucas Wiessing's work include HIV, Drug Use, Sexual Risk (54 papers), Hepatitis C virus research (35 papers) and HIV/AIDS Research and Interventions (31 papers). Lucas Wiessing is often cited by papers focused on HIV, Drug Use, Sexual Risk (54 papers), Hepatitis C virus research (35 papers) and HIV/AIDS Research and Interventions (31 papers). Lucas Wiessing collaborates with scholars based in Portugal, Netherlands and United Kingdom. Lucas Wiessing's co-authors include Louisa Degenhardt, Matthew Hickman, Bradley Mathers, Marica Ferri, Steffanie A. Strathdee, Blanca Iciar Indave, Gregorio Barrio, Luis Sordo, Roberto Pastor‐Barriuso and María J. Bravo and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Lucas Wiessing

81 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

2017 1.3k citations Louisa Degenhardt, Lucas Wiessing et al. profile →
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

2008 1.0k citations Louisa Degenhardt, Lucas Wiessing et al. profile →
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

2010 535 citations Louisa Degenhardt, Lucas Wiessing et al. profile →
Mortality among people who inject drugs: a systematic review and meta-analysis

2013 347 citations Louisa Degenhardt, Lucas Wiessing et al. profile →

Peers

Countries citing papers authored by Lucas Wiessing

Since Specialization

Citations

This map shows the geographic impact of Lucas Wiessing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Wiessing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Wiessing more than expected).

Fields of papers citing papers by Lucas Wiessing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Wiessing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Wiessing. The network helps show where Lucas Wiessing may publish in the future.

Co-authorship network of co-authors of Lucas Wiessing

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Wiessing. A scholar is included among the top collaborators of Lucas Wiessing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Wiessing. Lucas Wiessing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidemiology of HIV and Viral Hepatitis among People Who Inject Drugs in Europe 2017 ·Open Repository of the University of Porto (University of Porto) ·Lucas Wiessing	2
2	Could cannabis liberalisation lead to wider changes in drug policies and outcomes? 2017 ·International Journal of Drug Policy ·Brendan Hughes, Lucas Wiessing, Don C. Des Jarlais, Paul Griffiths	13
3	HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary—An expanding public health burden 2016 ·International Journal of Drug Policy ·(unknown), Mária Dudás, Lucas Wiessing, (unknown), (unknown), (unknown), (unknown)	23
4	Increasing prevalence of HIV infection among first time clients in Italian drug treatment services – is it sexual transmission? 2015 ·BMC Infectious Diseases ·Mario Cruciani, Lucas Wiessing, Giovanni Serpelloni, (unknown), (unknown), (unknown), Monica Zermiani, Barbara Suligoi	5
5	High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance 2015 ·BMC Infectious Diseases ·Magdalena Rosińska, Janusz Sierosławski, Lucas Wiessing	18
6	Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe 2014 ·AIDS ·Anneli Uusküla, Mait Raag, Cinta Folch, (unknown), (unknown), Maaike G. van Veen, (unknown), Magdalena Rosińska, Don C. Des Jarlais, Lucas Wiessing	5
7	Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening 2013 ·BMC Infectious Diseases ·Susan Hahné, Irene Veldhuijzen, Lucas Wiessing, Tek-Ang Lim, Mika Salminen, Marita van de Laar	185
8	Modelling HIV in the injecting drug user population and the male homosexual population in a developed country context 2012 ·Epidemics ·Andrew Sutton, Thomas House, Vivian Hope, Fortune Ncube, Lucas Wiessing, Mirjam Kretzschmar	12
9	Joint Modeling of HCV and HIV Co-Infection among Injecting Drug Users in Italy and Spain Using Individual Cross-Sectional Data 2011 ·Emanuele Del Fava, Ziv Shkedy, Niel Hens, Marc Aerts, Barbara Suligoi, Laura Camoni, Fernando Vallejo, Lucas Wiessing, Mirjam Kretzschmar	14
10	Seroprevalence of Blood-borne Infections and Population Sizes Estimates in a Population of Injecting Drug Users in Croatia 2010 ·Central European Journal of Public Health ·Branko Kolarić, (unknown), (unknown), Tomislav Rukavina, Lucas Wiessing	18
11	HIV in Portugal - the epidemic among injecting drug users 2009 ·Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) ·Lucas Wiessing, Isabelle Giraudon	0
12	A comparison between the force of infection estimates for blood‐borne viruses in injecting drug user populations across the European Union: a modelling study 2008 ·Journal of Viral Hepatitis ·Alex J. Sutton, Vivian Hope, Catharina Matheï, Viktor Mravčík, H Sebáková, Fernando Vallejo, Barbara Suligoi, M. Teresa Brugal, Fortune Ncube, Lucas Wiessing, Mirjam Kretzschmar	27
13	Surveillance of infectious diseases in IDUs across the EU: information from the EU expert network 2004 ·Weekly releases (1997–2007) ·Lucas Wiessing, Fortune Ncube, Dagmar Hedrich, Paul Griffiths, Vivian Hope, Noël Gill, F F Hamers, Luís de la Fuente, Irena Klavs, Pauli Leinikki, H Blystad, A. Meheus, Giovanni Rezza, Gerry V. Stimson, David Goldberg	2
14	Estimating the prevalence of problematic drug use: a review of methods and their application 2002 ·Bristol Research (University of Bristol) ·Matthew Hickman, Christopher G. Taylor, Avik Chatterjee, Louisa Degenhardt, Martin Frischer, Gordon Hay, Kate Tilling, Lucas Wiessing, Paul Griffiths, Rebecca McKetin	36
15	The epidemiology of drug use at the macro level: Indicators, models and policy-making 2001 ·Cineca Institutional Research Information System (Tor Vergata University) ·Lucas Wiessing, Richard Hartnoll, Carla Rossi	4
16	A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain 2001 ·Addiction ·Martin Frischer, Matthew Hickman, Ludwig Kraus, Fábio Mariani, Lucas Wiessing	70
17	Methodological guidelines to estimate the prevalence of problem drug use on the local level. 1999 ·Archives of Disease in Childhood ·Richard Hartnoll, Martin Frischer, Lucas Wiessing, (unknown), Ludwig Kraus, Neil McKeganey, Daniela D’Ippoliti, Antònia Domingo‐Salvany, Filip Smit, Gordon Hay	29
18	Methods for estimating HIV prevalence: A comparison of extrapolation from surveys on infection rate and risk behaviour with back-calculation for the Netherlands 1998 ·European Journal of Epidemiology ·H Houweling, Siem H. Heisterkamp, Lucas Wiessing, Roel A. Coutinho, J.K. van Wijngaarden, (unknown)	6
19	Modelling the spread of HIV in social networks of injecting drug users 1998 ·AIDS ·Mirjam Kretzschmar, Lucas Wiessing	62
20	The Dutch famine birth cohort study: design, validation of exposure, and selected characteristics of subjects after 43 years follow‐up 1993 ·Paediatric and Perinatal Epidemiology ·L. H. Lumey, Anita C.J. Ravelli, Lucas Wiessing, Janna G. Koppe, P.E. Treffers, Zena Stein	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact